Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07691359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Osteoporotic Fracture and Lidocaine Plaster 5% for Neuropathic Pain preventioN

Study acronym: FLYNN
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Osteoporotic vertebral fractures may lead to chronic pain with a neuropathic component, which is often underdiagnosed and undertreated in older adults. This proof-of-concept randomized controlled trial aims to evaluate whether early application of a 5% lidocaine plaster can prevent the development of neuropathic pain following an osteoporotic vertebral fracture. Participants will be randomized in a 2:1 ratio to receive either a daily 5% lidocaine plaster plus standard care or standard care alone for 2 months. The primary outcome is the proportion of participants who develop neuropathic pain at 2 months, assessed using the PainDETECT questionnaire.
Trial Details
NCT Number NCT07691359
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions
(from sponsor)		 Osteoporotic Vertebral Fracture, Neuropathic Pain
Related terms Neuralgia, Osteoporosis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov